Oscotec Inc. (039200.KQ)
KRW 29900.0
(-0.99%)
KRW 29900.0
(-0.99%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 24.61 Billion KRW | 144.05% |
| 2022 | 10.08 Billion KRW | 39.07% |
| 2021 | 7.25 Billion KRW | 321.19% |
| 2020 | 1.72 Billion KRW | -74.36% |
| 2019 | 6.71 Billion KRW | -40.27% |
| 2018 | 11.24 Billion KRW | -15.07% |
| 2017 | 13.23 Billion KRW | 12.68% |
| 2016 | 11.74 Billion KRW | -37.52% |
| 2015 | 18.8 Billion KRW | 71.57% |
| 2014 | 10.95 Billion KRW | -1.33% |
| 2013 | 11.1 Billion KRW | 0.0% |
| 2012 | - KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 29.42 Billion KRW | -64.31% |
| 2024 Q1 | 25.37 Billion KRW | 3.09% |
| 2023 Q1 | 11.64 Billion KRW | 15.49% |
| 2023 FY | 24.61 Billion KRW | 144.05% |
| 2023 Q2 | 14.56 Billion KRW | 25.01% |
| 2023 Q4 | 24.61 Billion KRW | 29.86% |
| 2023 Q3 | 18.95 Billion KRW | 30.17% |
| 2022 Q4 | 10.08 Billion KRW | 16.38% |
| 2022 Q3 | 8.66 Billion KRW | 0.9% |
| 2022 Q2 | 8.58 Billion KRW | 20.31% |
| 2022 Q1 | 7.13 Billion KRW | -1.56% |
| 2022 FY | 10.08 Billion KRW | 39.07% |
| 2021 FY | 7.25 Billion KRW | 321.19% |
| 2021 Q3 | 7.37 Billion KRW | 410.69% |
| 2021 Q2 | 1.44 Billion KRW | -23.81% |
| 2021 Q1 | 1.89 Billion KRW | 12.3% |
| 2021 Q4 | 7.25 Billion KRW | -1.61% |
| 2020 Q2 | 7.31 Billion KRW | -8.93% |
| 2020 Q1 | 8.03 Billion KRW | 23.66% |
| 2020 FY | 1.72 Billion KRW | -74.36% |
| 2020 Q4 | 1.68 Billion KRW | -71.54% |
| 2020 Q3 | 5.92 Billion KRW | -19.03% |
| 2019 Q1 | 11.38 Billion KRW | 1.24% |
| 2019 FY | 6.71 Billion KRW | -40.27% |
| 2019 Q4 | 6.49 Billion KRW | -44.31% |
| 2019 Q3 | 11.66 Billion KRW | 0.38% |
| 2019 Q2 | 11.62 Billion KRW | 2.14% |
| 2018 Q3 | 19.83 Billion KRW | 58.41% |
| 2018 Q2 | 12.51 Billion KRW | 1.25% |
| 2018 Q1 | 12.36 Billion KRW | -6.61% |
| 2018 FY | 11.24 Billion KRW | -15.07% |
| 2018 Q4 | 11.24 Billion KRW | -43.31% |
| 2017 FY | 13.23 Billion KRW | 12.68% |
| 2017 Q2 | 6.91 Billion KRW | -35.12% |
| 2017 Q4 | 13.23 Billion KRW | 114.73% |
| 2017 Q3 | 6.16 Billion KRW | -10.85% |
| 2017 Q1 | 10.65 Billion KRW | 0.11% |
| 2016 Q3 | 12.21 Billion KRW | -6.71% |
| 2016 FY | 11.74 Billion KRW | -37.52% |
| 2016 Q4 | 10.64 Billion KRW | -12.82% |
| 2016 Q2 | 13.09 Billion KRW | -21.39% |
| 2016 Q1 | 16.65 Billion KRW | -3.76% |
| 2015 Q3 | 10.73 Billion KRW | 2.98% |
| 2015 Q2 | 10.42 Billion KRW | 2.47% |
| 2015 Q1 | 10.17 Billion KRW | -7.14% |
| 2015 FY | 18.8 Billion KRW | 71.57% |
| 2015 Q4 | 17.3 Billion KRW | 61.16% |
| 2014 Q4 | 10.95 Billion KRW | 4.92% |
| 2014 Q3 | 10.44 Billion KRW | 3.92% |
| 2014 Q2 | 10.05 Billion KRW | -1.87% |
| 2014 Q1 | 10.24 Billion KRW | -7.78% |
| 2014 FY | 10.95 Billion KRW | -1.33% |
| 2013 Q4 | 11.1 Billion KRW | 12.73% |
| 2013 FY | 11.1 Billion KRW | 0.0% |
| 2013 Q3 | 9.85 Billion KRW | -0.88% |
| 2013 Q2 | 9.93 Billion KRW | -23.3% |
| 2013 Q1 | 12.95 Billion KRW | 0.0% |
| 2012 FY | - KRW | 0.0% |
| 2012 Q4 | - KRW | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| BCWORLD PHARM. Co., Ltd. | 91.84 Billion KRW | 73.201% |